Phase 3 Transplant Recipient Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Shingrix in Renal Transplant Recipients
Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting
Phase 2Phase 3
Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.
Liver Transplant Recipients
Institute of Liver and Biliary Sciences, India60 enrolled1 locationNCT06418893
Completed
Phase 3
Human Papilloma Virus (HPV) Vaccination in Special Risk Groups
Special Risk Groups
1. Paediatric Rheumatalogical Disease
2. Inflammatory Bowel Disease
3. Acute Lymphoblastic Leukaemia
4. Solid Organ Transplant Recipients (kidney and liver)
5. Chronic Renal Disease
6. Bone Marrow Transsplant
The response to the HPV vaccine will be studied within these 6 special risk groups.
National Health and Medical Research Council & Clinical Centre of Research Excellence(NHMRC CCRE) in Childhood and Adolescent Immunisation100 enrolled1 locationACTRN12609000571279
Recruiting
Phase 3
Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients.
Post transplant anaemia in renal transplant recipients.
Princess Alexandra hospital (Department of nephrology)100 enrolled1 locationACTRN12608000186358
Withdrawn
Phase 3
A Phase III Study Comparing Low Dose Cyclosporine, Methotrexate And Prednisone Versus Standard Dose Cyclosporine and Methotrexate As Graft Versus Host Disease Prophylaxis In Myeloblative Allogeneic Stem Cell Transplantation (ALLG BM10 trial). (Incorporating an Open-Label Sub-study Investigating The Use Of Valganciclovir In The Prevention Of Cytomegalovirus Infection In Hematopoietic Stem Cell Transplant Recipients (ML20712))
Prevention Of CytomegalovirusCell Transplant RecipientsProphylaxis In Myeloblative+3 more
Australasian Leukaemia and Lymphoma Group300 enrolled1 locationACTRN12607000347460
Completed
Phase 3
CeMyLungs
Heart Lung, Bilateral Lung and Single Lung Transplant recipients
Professor Allan R. Glanville320 enrolled1 locationACTRN12605000141640